Table 1.
Entire cohort | Surgical resection | Biopsy | |||||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | p | |
Patients | 55 | 100 | 25 | 45.5 | 30 | 54.5 | - |
Gender | |||||||
Female | 21 | 38.2 | 10 | 40 | 11 | 36.7 | 0.82 |
Male | 34 | 61.8 | 15 | 60 | 19 | 63.3 | 0.82 |
Age in years | |||||||
Median (IQR) | 66 | (57.5–73) | 62.3 | (50.5–66.9) | 68.5 | (62.1–76) | - |
Symptomatic at first presentation | |||||||
Memory impairment | 15 | 27.3 | 3 | 12 | 12 | 40 | 0.02 |
Confusion/mental status alteration | 38 | 69 | 17 | 68 | 21 | 70 | 0.87 |
Visual field deficit | 6 | 11 | 4 | 16 | 2 | 6.7 | 0.27 |
Aphasia | 10 | 18.2 | 7 | 28 | 3 | 10 | 0.08 |
Cranial nerve impairment | 2 | 3.6 | 1 | 4 | 1 | 3.3 | 0.89 |
Motor function impairment | 13 | 23.6 | 7 | 28 | 6 | 20 | 0.49 |
Sensory function impairment | 3 | 5.5 | 1 | 4 | 2 | 6.7 | 0.66 |
Psychiatric alteration | 1 | 1.8 | 0 | - | 1 | 3.3 | 0.36 |
Headache | 7 | 12.7 | 6 | 24 | 1 | 3.3 | 0.01 |
Epilepsy | 11 | 20 | 3 | 12 | 8 | 26.7 | 0.20 |
IQR, interquantile range